A SHORT REVIEW  ON POLYCYSTIC OVARY SYNDROME

Kavitha A; VEENA KIRAN S; SIRISHA K; NARENDRA BABU A; SATHISH KUMAR M

Kavitha A acharya nagarjuna university
VEENA KIRAN S Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.
SIRISHA K Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.
NARENDRA BABU A Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.
SATHISH KUMAR M Department of Pharmacology, Chalapathi Institute of Pharmaceutical Sciences, Lam, Guntur - 522 034, Andhra Pradesh, India.

Abstract

PolycysticÂ ovaryÂ syndromeÂ (PCOS)Â isÂ saidÂ toÂ beÂ theÂ commonestÂ endocrineÂ disorderÂ inÂ womenÂ ofÂ reproductiveÂ ageÂ withÂ aÂ heterogeneousÂ presentation,Â whichÂ includesÂ hyperandrogenismÂ andÂ ovulatoryÂ dysfunction.Â PolycysticÂ ovaryÂ syndromeÂ usuallyÂ hasÂ aÂ peri-pubertalÂ onset;theÂ presentÂ reviewÂ discussÂ aboutÂ theÂ causes,complications,risckÂ factors,dianosisÂ andÂ treatment.

KeyÂ words:PolycysticÂ ovaryÂ syndromeÂ (PCOS),Hyperandrogenism,Treatment

Author Biography

Kavitha A, acharya nagarjuna university

m.pharm pharmacology,rank 2

References

Polycystic ovary syndrome (PCOS) is said to be the commonest endocrine disorder in women of reproductive age with a heterogeneous presentation, which includes hyperandrogenism and ovulatory dysfunction. Polycystic ovary syndrome usually has a peri-pubertal onset;the present review discuss about the causes,complications,risck factors,dianosis and treatment.
Key words:Polycystic ovary syndrome (PCOS),Hyperandrogenism,Treatment